在患有心肌梗塞的老年患者中,完整或不完整的再血管:系统性审查和元分析
Cesar Intriago1, Cristopher-Josué Escudero2, Jesús Endara-Mina2
1Research, Larkin Community Hospital, South Miami, USA.
Cureus
|December 23, 2024
概括
对于接受皮肤冠状动脉干预 (PCI) 的老年人来说,完整的再血管化 (CR) 似乎没有比不完整的再血管化 (IR) 提供好处. 这次元分析发现,70岁及以上的患者的死亡率或不良事件没有显著减少.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 老年医学 老年医学
背景情况:
- 冠状动脉疾病 (CAD) 是美国的主要死亡原因.
- 穿皮冠状动脉干预 (PCI) 是急性CAD的标准治疗方法.
- 老年人有更高的心血管风险和独特的治疗考虑因素.
研究的目的:
- 在70岁及以上的患者中,评估完整重血管化 (CR) 与不完整重血管化 (IR) 的有效性.
- 为了在CR和IR之间比较主要的不良心血管事件 (MACE),心肌梗塞 (MI) 和全因死亡率 (ACM).
- 评估重血管化策略对老年人群心血管结果的影响.
主要方法:
- 通过文献搜索,发现了15项相关研究.
- 偏差风险使用偏差风险2 (RoB2) 和ROBINS-I工具进行评估.
- 进行了一项元分析来综合这些发现.
主要成果:
- 分析没有证明完全重血管化的优越性.
- CR没有显示出降低全因死亡率 (ACM) 或心肌梗塞 (MI) 的显著益处.
- 在老年人中,CR与IR相比,CR没有观察到重大心血管不良事件 (MACE) 的显著减少.
结论:
- 对于接受PCI的70岁及以上的患者来说,完整的再血管化 (CR) 似乎没有比不完整的再血管化 (IR) 提供额外的好处.
- 目前的证据不支持CR作为改善死亡率或减少这一特定人口中的不良事件的优越策略.
- 可能需要进一步的研究来澄清对患有CAD的老年患者的最佳再血管化策略.
相关概念视频
01:17Ischemic Heart Disease: Overview
3.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
01:27Coronary Artery Disease V: Interprofessional Care
444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
01:30Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
01:28Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522